Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance

BRCA1 plays a critical role in homology-directed repair (HDR) of DNA double strand breaks, and the repair defect of BRCA1-mutant cancer cells is being targeted with platinum drugs and poly (ADP-ribose) polymerase (PARP) inhibitors. We have employed relatively simple and sensitive assays to determine the function of BRCA1 variants or mutants in two HDR mechanisms, homologous recombination (HR) and single strand annealing (SSA), and in conferring resistance to cisplatin and olaparib in human cancer cells. Our results define the functionality of the top 22 patient-derived BRCA1 missense variants and the contribution of different domains of BRCA1 and its E3 ubiquitin ligase activity to HDR and drug resistance. Importantly, our results also demonstrate that the BRCA1-PALB2 interaction dictates the choice between HR and SSA. These studies establish functional and mutational landscapes of BRCA1 for HDR and therapy resistance, while revealing novel insights into BRCA1 regulatory mechanisms and HDR pathway choice. DOI: http://dx.doi.org/10.7554/eLife.21350.001

• Publication year

  2017

• Venue

  eLife

• Publication date

  2017-04-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7554/eLife.21350PMID 28398198PMCID 5432210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compromised BRCA1-PALB2 interaction is associated with breast cancer risk

  2017cited by this paper
• BRCAness revisited

  2016cited by this paper
• Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection

  2016cited by this paper
• Purified human BRCA 2 stimulates RAD 51-mediated recombination

  2016cited by this paper
• Patterns and functional implications of rare germline variants across 12 cancer types

  2015cited by this paper
• Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients

  2015cited by this paper
• Deciphering the BRCA1 Tumor Suppressor Network*

  2015cited by this paper
• Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention

  2014cited by this paper
• Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2

  2014influential reference
• CtIP-mediated resection is essential for viability and can operate independently of BRCA1

  2014cited by this paper
• A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity.

  2013cited by this paper
• Analysis of BRCA1 Variants in Double‐Strand Break Repair by Homologous Recombination and Single‐Strand Annealing

  2013cited by this paper
• A high-throughput functional complementation assay for classification of BRCA1 missense variants.

  2013cited by this paper
• The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression

  2013cited by this paper
• Mechanisms of resistance to therapies targeting BRCA-mutant cancers

  2013cited by this paper
• A guide for functional analysis of BRCA1 variants of uncertain significance

  2012cited by this paper
• I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks.

  2012cited by this paper
• PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function

  2012cited by this paper
• Links between genome integrity and BRCA1 tumor suppression.

  2012influential reference
• BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

  2011cited by this paper
• BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity

  2011influential reference
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

  2010cited by this paper
• Human BRCA2 protein promotes RAD51 filament formation on RPA-covered ssDNA

  2010cited by this paper
• BRCA1 and its toolbox for the maintenance of genome integrity

  2010cited by this paper
• Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

  2010cited by this paper
• 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.

  2010cited by this paper
• Purified human BRCA2 stimulates RAD51-mediated recombination

  2010cited by this paper
• Structural basis for recruitment of BRCA2 by PALB2

  2009cited by this paper
• The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

  2009cited by this paper
• PALB2 is an integral component of the BRCA complex required for homologous recombination repair

  2009influential reference
• PALB2 links BRCA1 and BRCA2 in the DNA-damage response.

  2009cited by this paper
• Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

  2009cited by this paper
• PALB 2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA 1 and BRCA 2

  2009cited by this paper
• PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2

  2009cited by this paper
• E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks

  2008influential reference
• The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression

  2008cited by this paper
• Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

  2007cited by this paper
• Human CtIP promotes DNA end resection

  2007cited by this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cited by this paper
• Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

  2006cited by this paper
• BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution

  2006cited by this paper
• The role of BRCA1 in transcriptional regulation and cell cycle control

  2006cited by this paper
• BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.

  2006cited by this paper
• Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.

  2006cited by this paper
• Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling

  2006cited by this paper
• Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.

  2005cited by this paper
• Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain.

  2004cited by this paper
• Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences

  2004influential reference
• Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

  2003cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002influential reference
• Mutation in Brca2 stimulates error‐prone homology‐directed repair of DNA double‐strand breaks occurring between repeated sequences

  2001cited by this paper
• BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001influential reference
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001influential reference
• Identification of a Functional Nuclear Export Sequence in BRCA1*

  2000cited by this paper
• Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

  1998cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor*

  1996cited by this paper
• DNA strand annealing is promoted by the yeast Rad52 protein.

  1996cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper

• New twist on BRCA1-mediated DNA recombination repair and tumor suppression.

  2025cites this paper
• BRCA1 and BRCA2 in DNA damage and replication stress response: Insights into their functions, mechanisms, and implications for cancer treatment.

  2025cites this paper
• Prime Editing: Mechanistic Insights and DNA Repair Modulation

  2025cites this paper
• An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance

  2025influential citation
• Functional characterization of BRCA1 variants of unknown significance using homologous recombination repair assays

  2025cites this paper
• Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk

  2025cites this paper
• Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing

  2024cites this paper
• PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response

  2024cites this paper
• Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity

  2024cites this paper
• EXO1 protects BRCA1-deficient cells against toxic DNA lesions.

  2024cites this paper
• A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer

  2024cites this paper
• Proline variants in the BRCA1 coiled‐coil domain disrupt folding and binding to PALB2

  2024cites this paper
• Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

  2024cites this paper
• Functional Analysis of BARD1 Missense Variants on Homology‐Directed Repair in Ovarian and Breast Cancers

  2024cites this paper
• Uncovering novel pathogenic variants and pathway mutations in triple-negative breast cancer among the endogamous mizo tribe

  2024cites this paper
• The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway

  2024cites this paper
• Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions

  2023cites this paper
• Multiplexed assay of variant effect reveals residues of functional importance in the BRCA1 coiled-coil and serine cluster domains

  2023cites this paper
• Double‐strand DNA break repair: molecular mechanisms and therapeutic targets

  2023cites this paper
• Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.

  2023cites this paper
• Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model

  2023cites this paper
• BRCA1 frameshift variants leading to extended incorrect protein C termini

  2023cites this paper
• Radiation Therapy in Patients with Germline Mutations: a Review of the Current Evidence

  2023cites this paper
• Actionability classification of variants of unknown significance correlates with functional effect

  2023cites this paper
• The MALAT1-breast cancer interplay: insights and implications

  2023cites this paper
• Genetics and Epigenetics of Breast Cancer

  2023cites this paper
• Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival

  2023cites this paper
• BRCA1–BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes

  2023cites this paper
• EXO1-mediated DNA repair by single-strand annealing is essential for BRCA1-deficient cells

  2023cites this paper
• Spectroscopic studies on noncovalent binding of nicotinamide-modified BRCA1 (856-871) analogs to calf thymus DNA.

  2023cites this paper
• Functional Analysis of Variants in BRCA1 Using CRISPR Base Editors.

  2023cites this paper
• Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2

  2022cites this paper
• The BRCA1 BRCT promotes antisense RNA production and double-stranded RNA formation to suppress ribosomal R-loops

  2022cites this paper
• BRCA1-dependent and independent recruitment of PALB2-BRCA2-RAD51 in the DNA damage response and cancer.

  2022cites this paper
• Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma

  2022cites this paper
• Characterization of Synonymous BRCA1:c.132C>T as a Pathogenic Variant

  2022cites this paper
• The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families

  2021cites this paper
• Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample

  2021cites this paper
• Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies

  2021cites this paper
• Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer

  2021cites this paper
• Novel fluorescent-based reporter cell line engineered for monitoring homologous recombination events

  2021cites this paper
• A Validated Functional Analysis of PALB2 (Partner and Localizer of BRCA2) Missense Variants for Use in Clinical Variant Interpretation.

  2021cites this paper
• Small‐molecule Effectors of DNA Repair Proteins: Applications for Development of Cancer Therapeutics and Research

  2021cites this paper
• ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G2–M Checkpoint Maintenance

  2021cites this paper
• Roles of circRNAs in cancer chemoresistance (Review).

  2021cites this paper
• A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair

  2021cites this paper
• Evaluation of DNA double-strand break repair capacity in human cells: Critical overview of current functional methods.

  2021cites this paper
• A protein interaction landscape of breast cancer

  2021cites this paper
• Novel Insights Into MALAT1 Function as a MicroRNA Sponge in NSCLC

  2021cites this paper
• Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment

  2021cites this paper
• BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin

  2021cites this paper
• Single‐strand annealing: Molecular mechanisms and potential applications in CRISPR‐Cas‐based precision genome editing

  2021cites this paper
• Structural characterization of clinically reported missense mutations identified in BRCA1

  2021cites this paper
• Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management

  2020cites this paper
• Synthetic CRISPR/Cas9 reagents facilitate genome editing and homology directed repair

  2020cites this paper
• PALB2 Variants: Protein Domains and Cancer Susceptibility.

  2020cites this paper
• BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ

  2020cites this paper
• Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance

  2020cites this paper
• Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1

  2020cites this paper
• A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance.

  2020cites this paper
• Variants of the human RAD52 gene confer defects in ionizing radiation resistance and homologous recombination repair in budding yeast

  2020cites this paper
• Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays

  2020cites this paper
• A Validated Functional Analysis of PALB2 Missense Variants for Use in Clinical Variant Interpretation

  2020cites this paper
• LESSONS LEARNED FROM UNDERSTANDING CHEMOTHERAPY RESISTANCE IN EPITHELIAL TUBO-OVARIAN CARCINOMA FROM BRCA1 AND BRCA2 MUTATION CARRIERS.

  2020cites this paper
• A meta-analysis of clinical cases of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance

  2020cites this paper
• Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis

  2020cites this paper
• Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays

  2020cites this paper
• Screening of BRCA1 variants c.190T>C, 1307delT, g.5331G>A and c.2612C>T in breast cancer patients from North India

  2020cites this paper
• RNF8 has both KU-dependent and independent roles in chromosomal break repair

  2020cites this paper
• BRCA1 Mutational Complementation Induces Synthetic Viability.

  2020cites this paper
• DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

  2020cites this paper
• Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation

  2020cites this paper
• BRCA gene mutations: A population based review

  2019cites this paper
• Impeding the single-strand annealing pathway of DNA double-strand break repair by withaferin A-mediated FANCA degradation.

  2019cites this paper
• Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation

  2019cites this paper
• Harnessing DNA Double-Strand Break Repair for Cancer Treatment

  2019cites this paper
• Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.

  2019cites this paper
• Antiparallel Coiled-Coil Interactions Mediate Homodimerization of the DNA Damage Repair Protein, PALB2

  2019cites this paper
• Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency

  2019cites this paper
• How cells ensure correct repair of DNA double-strand breaks

  2018cites this paper
• Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.

  2018cites this paper
• Repeat-mediated deletions can be induced by a chromosomal break far from a repeat, but multiple pathways suppress such rearrangements

  2018cites this paper
• Acquired resistance of phosphatase and tensin homolog‐deficient cells to poly(ADP‐ribose) polymerase inhibitor and Ara‐C mediated by 53BP1 loss and SAMHD1 overexpression

  2018cites this paper
• BP 1 deposition at DSBs to stimulate single-strand annealing repair

  2018cites this paper
• A total synthetic approach to CRISPR/Cas9 genome editing and homology directed repair

  2018cites this paper
• Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

  2018influential citation
• Antiparallel Coiled-Coil Interactions Mediate the Homodimerization of the DNA Damage-Repair Protein PALB2.

  2018cites this paper
• BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance

  2018cites this paper
• RNF169 limits 53BP1 deposition at DSBs to stimulate single-strand annealing repair

  2018cites this paper
• Stitching up broken DNA ends by FANCA

  2018cites this paper
• Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells

  2018cites this paper
• Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction

  2018cites this paper
• BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites

  2017cites this paper
• BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites

  2017cites this paper
• Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy.

  2017cites this paper
• ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair

  2017cites this paper